Drug Profile
Porcine neural cell product-PD
Alternative Names: NeuroCell-PDLatest Information Update: 01 Apr 2022
Price :
$50
*
At a glance
- Originator Diacrin; Genzyme Corporation
- Developer Diacrin
- Class Antiparkinsonians; Neuroprotectants
- Mechanism of Action Dopaminergic cell replacements
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Discontinued Parkinson's disease